CDC42BPA

CDC42BPA (MRCKα) is a serine/threonine kinase that functions as a downstream effector linking Rho-family GTPase and growth-factor signaling to actomyosin cytoskeletal organization, driving directional cell migration, epithelial barrier integrity, and contractility (PMID:25092657, PMID:33507884). Downstream of EGF, PDK1 binds and activates MRCKα — independently of PDK1 kinase activity but dependent on its PIP3 membrane recruitment — and the two colocalize in lamellipodia to couple growth-factor signaling to myosin contraction and directional migration (PMID:25092657). MRCKα activates myosin light chain to enforce epithelial functions: it cooperates with the Na+,K+-ATPase β1 subunit to upregulate tight-junction proteins and maintain alveolar barrier function, and restoring MRCKα in vivo attenuates LPS-induced acute lung injury (PMID:33507884, PMID:34675326). During apoptosis, caspase cleavage generates an active MRCKα fragment sufficient to assemble an apical actomyosin ring that compacts and extrudes dying epithelial cells (PMID:29162624). MRCKα also constrains RhoA signaling by phosphorylating the RhoA-GEF GEF-H1 (ARHGEF2) on Ser174, suppressing GEF-H1 activity; loss of MRCKα elevates GEF-H1/RhoA/MRTF signaling, stress fibre formation, and fibrogenic gene programs including ACTA2 (PMID:41726953, PMID:41827880). Beyond cytoskeletal effectors, MRCKα directly phosphorylates Gli2 to promote its ciliary/nuclear localization and Hedgehog transcriptional output, and negatively regulates surface expression of the canalicular transporter ABCB4 via myosin regulatory light chain (PMID:37019250, PMID:35203270). MRCKα expression is itself controlled post-transcriptionally by iron through a functional 3′UTR iron-responsive element, and the kinase participates in transferrin-receptor-mediated iron uptake (PMID:16412980, PMID:20188707).

1. 2006 Medium

   Established that MRCKα is not constitutively expressed but is post-transcriptionally tuned by cellular iron via a functional IRE, embedding the kinase in iron homeostasis regulation.

   Evidence Bioinformatic IRE identification and biochemical mRNA stability assays under varying iron conditions

   PMID:16412980

   Open questions at the time

   • Does not identify which IRE-binding proteins act on the MRCKα transcript
   • Does not connect IRE regulation to a kinase-dependent function
2. 2007 Medium

   Placed MRCKα downstream of Notch1 tumor-suppression, showing its upregulation cooperates with oncogenic Ras in keratinocyte carcinogenesis.

   Evidence Genetic and pharmacological Notch suppression with oncogenic Ras in primary keratinocytes and mouse grafts

   PMID:17344417

   Open questions at the time

   • Mechanism by which MRCKα promotes SCC not resolved at the substrate level
   • Co-upregulation with ROCK1/2 leaves relative contribution unclear
3. 2010 Medium

   Linked iron-regulated MRCKα to a cellular function — transferrin receptor endocytosis/trafficking — implicating its cytoskeletal activity in iron uptake.

   Evidence shRNA knockdown, colocalization with Tf-loaded TfR, and iron uptake assay

   PMID:20188707

   Open questions at the time

   • The cytoskeletal step in TfR endocytosis controlled by MRCKα is not defined
   • No kinase substrate identified in this pathway
4. 2014 High

   Defined the upstream activation mechanism, showing PDK1 binds and activates MRCKα via PIP3-dependent membrane recruitment to couple EGF signaling to lamellipodial myosin contraction and directional migration.

   Evidence Reciprocal Co-IP, kinase-dead PDK1 mutants, lamellipodia retraction and migration assays with knockdown/rescue

   PMID:25092657

   Open questions at the time

   • How PDK1 binding activates MRCKα kinase mechanistically is not detailed
   • Does not map the relevant phosphorylation events on MRCKα
5. 2017 High

   Demonstrated MRCKα drives a discrete morphogenetic event — assembly of an apical actomyosin ring for apoptotic epithelial extrusion — activated by caspase cleavage.

   Evidence Live imaging, expression of the caspase-cleavage product, F-actin flow and myosin inhibition, extrusion assays

   PMID:29162624

   Open questions at the time

   • Caspase cleavage site and the resulting activation mechanism not fully mapped
   • Substrates within the extrusion ring not enumerated
6. 2017 Medium

   Positioned MRCKα as a rigidity-independent contractility module, with an ICAP-1/Smurf1 ubiquitylation switch toggling between ROCK2- and MRCKα-mediated contractility.

   Evidence Non-ubiquitylatable ICAP-1 mutants, MLC phosphorylation assays, migration on variable-stiffness substrates

   PMID:28049720

   Open questions at the time

   • Direct biochemical link between ICAP-1 and MRCKα activation not established
   • How the switch selects MRCKα over ROCK2 mechanistically unclear
7. 2021 Medium

   Connected MRCKα to epithelial barrier maintenance, showing it binds the Na+,K+-ATPase β1 subunit and uses MLC phosphorylation to upregulate tight junction proteins, with in vivo rescue of acute lung injury.

   Evidence Co-IP/MS, inducible overexpression and knockdown, barrier assays, and in vivo LPS-ALI gene transfer

   PMID:33507884 PMID:34675326

   Open questions at the time

   • Direct MRCKα substrate driving tight-junction upregulation not identified
   • Whether NKA β1 directly modulates MRCKα kinase activity is unclear
8. 2021 Medium

   Tested in vivo requirement in cancer, revealing functional redundancy: dual MRCKα/β loss reduces TNBC invasion, but single MRCKα knockout has no developmental or mammary tumor phenotype.

   Evidence Conditional MRCKα knockout mice, MMTV-PyMT model, and double-knockout invasion assays

   PMID:33921698

   Open questions at the time

   • Does not dissect distinct versus redundant roles of MRCKα and MRCKβ
   • Negative in vivo single-KO result limits inference on isolated MRCKα function
9. 2022 High

   Identified ABCB4 as a regulated target, showing MRCKα and MRLC bind ABCB4 and MRCKα negatively controls its surface expression, extending the kinase into membrane transporter trafficking.

   Evidence Co-IP plus convergent loss-of-function (DN mutant, inhibitor, RNAi, CRISPR-KO) and surface expression assays in hepatocytes and HEK-293

   PMID:35203270

   Open questions at the time

   • The MRLC-dependent trafficking step controlling ABCB4 not mechanistically resolved
   • Whether MRCKα phosphorylates ABCB4 directly not addressed
10. 2022 Medium

    Extended MRCKα into metabolic/secretory signaling, placing it in a PI3K→MRCKα→Akt→mTOR/SREBP1/cyclin D1 axis driving prolactin- and amino-acid-stimulated lactogenesis.

    Evidence Bidirectional knockdown/overexpression with pharmacological pathway inhibitors in bovine mammary epithelial cells

    PMID:35891685 PMID:40487111

    Open questions at the time

    • Direct MRCKα substrate in the mTOR pathway not identified
    • Findings restricted to bovine mammary cells; human relevance not tested
11. 2023 High

    Revealed a non-cytoskeletal substrate, establishing MRCKα as a direct Gli2 kinase that promotes Gli2 localization, promoter binding, and Hedgehog transcriptional output.

    Evidence In vitro kinase assay, Co-IP, MRCKα/β CRISPR double-knockout, Gli2 localization and ChIP

    PMID:37019250

    Open questions at the time

    • Specific Gli2 phosphosites and their functional consequences not mapped
    • Relative roles of MRCKα versus MRCKβ in Hedgehog output unresolved
12. 2026 High

    Defined a RhoA-restraining function, showing MRCKα phosphorylates GEF-H1 on Ser174 to suppress GEF-H1/RhoA/MRTF signaling, controlling spheroid compaction and fibrogenic gene programs.

    Evidence MS-identified interaction, Co-IP, PLA, Ser174 phosphosite mapping, RhoA/GEF-H1 activity assays, MRTF translocation, 3D organoids, and in vivo kidney fibrosis model

    PMID:41726953 PMID:41827880

    Open questions at the time

    • One key supporting study is a preprint (41726953)
    • How TGFβ1 enhances GEF-H1/MRCKα binding mechanistically not resolved
13. 2025 Low

    Proposed a metabolite-based inhibitory regulation, with D2HG-mediated O-2-hydroxyglutarylation associated with reduced MRCKα substrate phosphorylation.

    Evidence Chemical proteomics and substrate phosphorylation comparison (preprint)

    PMID:bio_10.1101_2025.01.24.634716

    Open questions at the time

    • Preprint; modification site and direct effect on kinase activity not dissected
    • MRCKα is one of two kinases briefly examined, limiting specificity

• The unifying question of how distinct upstream inputs (PDK1/EGF, caspase cleavage, ICAP-1 switch, metabolite modification) selectively direct MRCKα toward its diverse substrates (MLC, GEF-H1, Gli2, ABCB4) remains unresolved.
• No structural model linking activation mode to substrate selection
• Functional separation of MRCKα from redundant MRCKβ not established across contexts